Status:
COMPLETED
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Postoperative Pain
Eligibility:
All Genders
16+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.
Detailed Description
The duration of treatment is 24 hours.
Eligibility Criteria
Inclusion
- Impaction of a molar tooth requiring removal
Exclusion
- Known allergy to the study drugs
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2002
Estimated Enrollment :
271 Patients enrolled
Trial Details
Trial ID
NCT00092313
Start Date
June 1 2002
End Date
September 1 2002
Last Update
November 25 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.